Home > Insider Trading > Filing (0001209191-20-043393)

Filing Details

Accession Number:: 0001209191-20-043393
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-22 19:13:54
Reporting Period:: 2020-07-20

Accepted Time:: 2020-07-22 19:13:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1801754	Trean Insurance Group Inc.	TIG	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777244	Daniel Tully	C/O Trean Insurance Group, Inc. 150 Lake Street West Wayzata MN 55391		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	Disposition	2020-07-20	18	$13.95	329	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.01 Per Share	Disposition	2020-07-20	1,285,669	$13.95	23,854,902	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.01 Per Share	Disposition	2020-07-20	4	$13.95	76	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.01 Per Share	Disposition	2020-07-20	294,591	$13.95	5,465,970	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.01 Per Share	Disposition	2020-07-22	12	$13.95	317	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.01 Per Share	Disposition	2020-07-22	851,693	$13.95	23,003,209	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.01 Per Share	Disposition	2020-07-22	3	$13.95	73	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.01 Per Share	Disposition	2020-07-22	195,152	$13.95	5,270,818	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Footnotes

Pursuant to an underwriting agreement, dated July 15, 2020 (the "Underwriting Agreement"), and in connection with the registered public offering of shares of common stock of the Issuer, pursuant to the final prospectus supplement dated July 15, 2020, which sale was completed on July 20, 2020, the underwriters purchased, and each of AHP-TH LLC, AHP-BHC LLC, ACP-TH LLC and ACP-BHC LLC, as selling stockholders (collectively, the "Selling Stockholders"), sold, an aggregate of 1,580,282 shares of common stock of the Issuer.
The securities are held of record by AHP-TH LLC.
Altaris Health Partners III, L.P. is the sole owner of each of AHP-TH LLC and AHP-BHC LLC, and may be deemed to beneficially own the shares of common stock of the Issuer owned by each of AHP-TH LLC and AHP-BHC LLC. AHP III GP, L.P. is the general partner of Altaris Health Partners III, L.P., and may be deemed to beneficially own the shares of common stock of the Issuer beneficially owned by Altaris Health Partners III, L.P. Altaris Partners, LLC is the general partner of AHP III GP, L.P., and may be deemed to beneficially own the shares of common stock of the Issuer beneficially owned by AHP III GP, L.P.
George Aitken-Davies and Mr. Tully are the Managers of Altaris Partners, LLC. Each of Mr. Aitken-Davies and Mr. Tully is in a position directly and indirectly to determine the investment and voting decisions made by Altaris Partners, LLC and the affiliated entities listed above. Mr. Aitken-Davies and Mr. Tully may each be deemed to have voting and investment power with respect to all shares of common stock of the Issuer held beneficially by Altaris Partners, LLC through the reporting persons described in these footnotes.
Mr. Tully disclaims beneficial ownership of all shares of common stock of the Issuer except to the extent of his or its pecuniary interest therein.
The securities are held of record by AHP-BHC LLC.
The securities are held of record by ACP-TH LLC.
Altaris Constellation Partners, L.P. is the sole owner of each of ACP-TH LLC and ACP-BHC LLC, and may be deemed to beneficially own the shares of common stock of the Issuer owned by each of ACP-TH LLC and ACP-BHC LLC. AHP Constellation GP, L.P. is the general partner of Altaris Constellation Partners, L.P., and may be deemed to beneficially own the shares of common stock of the Issuer beneficially owned by Altaris Constellation Partners, L.P. Altaris Partners, LLC is the general partner of AHP Constellation GP, L.P., and may be deemed to beneficially own the shares of common stock of the Issuer beneficially owned by AHP Constellation GP, L.P.
The securities are held of record by ACP-BHC LLC.
The underwriters' purchase of additional shares of common stock from the Selling Stockholders pursuant to the underwriters' over-allotment option under the Underwriting Agreement closed on July 22, 2020.